Insights
Operating cash flow versus EBITDA across the Annolyse coverage set, using each company's most recent published result.
Last updated 3 June 2026
OCF / EBITDA across covered companies and periods; extreme denominator effects above 1,000% are omitted from the chart.
Source: latest published result per company in the current Annolyse coverage set.
Copy, export, or share this public Annolyse data reference.
Cash conversion is not telling a single story across the coverage set. PGW screens worst, but that first-half weakness is structurally seasonal for its working-capital cycle. At the other end, KMD's very high ratio is driven by working-capital release rather than healthy underlying earnings, while SCT's fall from 119.2% to 46.9% is the clearest deterioration among the cleaner operating businesses.
Related insights
Payout ratios against NPAT and free cash flow for the latest published result from each covered company.
Net debt and net debt / EBITDA across the Annolyse coverage set, ranked by the latest reported leverage position.
PBT versus NPAT divergence across covered NZX companies, highlighting tax, fair-value, and non-operating distortions.
Revenue growth rates across covered NZX companies, ranked by each company's latest reported period.
Return on equity across covered NZX companies, with prior-period movement and leverage context.
Debtor days and inventory days across covered NZX companies, showing where cash is tied up in receivables or stock.
Get the next relevant NZX result briefings and refreshed comparison views by email.